Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study.Published in:2010By:Gudbjornsson B;Thorsteinsson S;Sigvaldason H;Einarsdottir R;Johannsson M;Zoega H;Halldorsson M;Thorgeirsson GPublication type:Journal Article
Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.Published in:European Journal of Clinical Microbiology & Infectious Diseases, 2012, v. 31, n. 10, p. 2601, doi. 10.1007/s10096-012-1603-0By:Vesteinsdottir, I.;Gudlaugsdottir, S.;Einarsdottir, R.;Kalaitzakis, E.;Sigurdardottir, O.;Bjornsson, E.Publication type:Article